Literature DB >> 26393465

Single Nucleotide Polymorphisms in the BDNF, VDR, and DNASE 1 Genes in Dry Eye Disease Patients: A Case-Control Study.

Joelle A Hallak1, Sapna Tibrewal2, Neil Mohindra2, Xiaoyi Gao3, Sandeep Jain2.   

Abstract

PURPOSE: To identify single nucleotide polymorphisms (SNPs) in the brain-derived neurotrophic factor (BDNF), vitamin D receptor (VDR), and DNASE1 genes that may be associated with dry eye disease (DED), and determine whether this association varies by the presence of depression.
METHODS: A case-control study was performed with 64 DED cases and 51 controls. We collected 2 mL of saliva following a routine eye exam. Genotyping was performed using both custom and predesigned TaqMan SNP genotyping assays for 12 hypothesized SNPs. Genotype and allele frequencies of cases and controls were evaluated. Odds ratios were calculated for allele frequencies. Stratified analysis was performed to determine if the association between SNPs and DED varied by depression status.
RESULTS: A total of 18% of cases had the minor allele A of Val66Met (rs6265) SNP in the BDNF gene compared with 9% of the controls (P = 0.05). Odds ratio was 2.22. Two SNPs (Fokl-rs2228570 and Apal-rs7975232) in the VDR genes also varied between DED cases and controls. Cases were 1.72 and 1.66 times more likely to have the minor allele A in rs2228570 and rs7975232, respectively, than controls (P = 0.06 for both). While not statistically significant, among patients with depression, DED cases were 3.93 times more likely to have the minor allele A of the Val66Met SNP compared to controls.
CONCLUSIONS: This pilot study showed that Val66Met in the BDNF gene and two SNPs, Fokl and Apal, in the VDR gene may potentially be associated with DED. Additionally, the association between DED and Val66Met may vary by depression status.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26393465      PMCID: PMC5102496          DOI: 10.1167/iovs.15-17036

Source DB:  PubMed          Journal:  Invest Ophthalmol Vis Sci        ISSN: 0146-0404            Impact factor:   4.799


  33 in total

1.  Effect of androgen deficiency on the human meibomian gland and ocular surface.

Authors:  K L Krenzer; M R Dana; M D Ullman; J M Cermak; D B Tolls; J E Evans; D A Sullivan
Journal:  J Clin Endocrinol Metab       Date:  2000-12       Impact factor: 5.958

Review 2.  Vitamin D and the brain.

Authors:  Lauren R Harms; Thomas H J Burne; Darryl W Eyles; John J McGrath
Journal:  Best Pract Res Clin Endocrinol Metab       Date:  2011-08       Impact factor: 4.690

3.  Hippocampal volumes and the brain-derived neurotrophic factor val66met polymorphism in geriatric major depression.

Authors:  Dora Kanellopoulos; Faith M Gunning; Sarah S Morimoto; Matthew J Hoptman; Christopher F Murphy; Robert E Kelly; Charles Glatt; Kelvin O Lim; George S Alexopoulos
Journal:  Am J Geriatr Psychiatry       Date:  2011-01       Impact factor: 4.105

4.  The association between dry eye disease and depression and anxiety in a large population-based study.

Authors:  Robert van der Vaart; Mark A Weaver; Chelsea Lefebvre; Richard Marc Davis
Journal:  Am J Ophthalmol       Date:  2014-11-26       Impact factor: 5.258

5.  Human cathelicidin antimicrobial peptide (CAMP) gene is a direct target of the vitamin D receptor and is strongly up-regulated in myeloid cells by 1,25-dihydroxyvitamin D3.

Authors:  Adrian F Gombart; Niels Borregaard; H Phillip Koeffler
Journal:  FASEB J       Date:  2005-07       Impact factor: 5.191

6.  Association between depression and dry eye disease in an elderly population.

Authors:  Ki Woong Kim; Sang Beom Han; Eun Ryung Han; Se Joon Woo; Jung Jae Lee; Jong Chul Yoon; Joon Young Hyon
Journal:  Invest Ophthalmol Vis Sci       Date:  2011-10-10       Impact factor: 4.799

7.  Serum tumour necrosis factor-alpha is associated with poor health-related quality of life and depressive symptoms in patients with systemic lupus erythematosus.

Authors:  A Mak; C S Tang; R C Ho
Journal:  Lupus       Date:  2013-01-18       Impact factor: 2.911

8.  The BDNF Val66Met polymorphism impacts parahippocampal and amygdala volume in healthy humans: incremental support for a genetic risk factor for depression.

Authors:  C Montag; B Weber; K Fliessbach; C Elger; M Reuter
Journal:  Psychol Med       Date:  2009-04-01       Impact factor: 7.723

9.  Serum DNase I activity in systemic lupus erythematosus: correlation with immunoserological markers, the disease activity and organ involvement.

Authors:  Dusan Skiljevic; Ivica Jeremic; Milos Nikolic; Sladjana Andrejevic; Mirjana Sefik-Bukilica; Biljana Stojimirovic; Branka Bonaci-Nikolic
Journal:  Clin Chem Lab Med       Date:  2013-05       Impact factor: 3.694

10.  Proinflammatory gene polymorphisms are potentially associated with Korean non-Sjogren dry eye patients.

Authors:  Kyung-Sun Na; Jee-Won Mok; Ja Yeon Kim; Choun-Ki Joo
Journal:  Mol Vis       Date:  2011-10-29       Impact factor: 2.367

View more
  5 in total

Review 1.  Vitamin D, the Vitamin D Receptor, Calcitriol Analogues and Their Link with Ocular Diseases.

Authors:  Miłosz Caban; Urszula Lewandowska
Journal:  Nutrients       Date:  2022-06-05       Impact factor: 6.706

2.  Dry eye disease and psychiatric disorders: A systematic review and meta-analysis.

Authors:  Amy Basilious; Cathy Y Xu; Monali S Malvankar-Mehta
Journal:  Eur J Ophthalmol       Date:  2021-12-22       Impact factor: 1.922

Review 3.  Association of dry eye disease with psychiatric or neurological disorders in elderly patients.

Authors:  Sang Beom Han; Hee Kyung Yang; Joon Young Hyon; Won Ryang Wee
Journal:  Clin Interv Aging       Date:  2017-05-15       Impact factor: 4.458

4.  Lower Serum Vitamin D Level Was Associated with Risk of Dry Eye Syndrome.

Authors:  Yi-Fang Meng; Jiong Lu; Qian Xing; Jian-Jun Tao; Pan Xiao
Journal:  Med Sci Monit       Date:  2017-05-10

Review 5.  Do epigenetic changes caused by commensal microbiota contribute to development of ocular disease? A review of evidence.

Authors:  Ashima Nayyar; Sofya Gindina; Arturo Barron; Yan Hu; John Danias
Journal:  Hum Genomics       Date:  2020-03-13       Impact factor: 4.639

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.